153 related articles for article (PubMed ID: 26647820)
1. Quantifying replicative senescence as a tumor suppressor pathway and a target for cancer therapy.
Rodriguez-Brenes IA; Wodarz D; Komarova NL
Sci Rep; 2015 Dec; 5():17660. PubMed ID: 26647820
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of replicative immortality.
Yaswen P; MacKenzie KL; Keith WN; Hentosh P; Rodier F; Zhu J; Firestone GL; Matheu A; Carnero A; Bilsland A; Sundin T; Honoki K; Fujii H; Georgakilas AG; Amedei A; Amin A; Helferich B; Boosani CS; Guha G; Ciriolo MR; Chen S; Mohammed SI; Azmi AS; Bhakta D; Halicka D; Niccolai E; Aquilano K; Ashraf SS; Nowsheen S; Yang X
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S104-S128. PubMed ID: 25869441
[TBL] [Abstract][Full Text] [Related]
3. Induced senescence in HeLa cervical carcinoma cells containing elevated telomerase activity and extended telomeres.
Goodwin EC; DiMaio D
Cell Growth Differ; 2001 Nov; 12(11):525-34. PubMed ID: 11714633
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
Fuxe J; Akusjärvi G; Goike HM; Roos G; Collins VP; Pettersson RF
Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
[TBL] [Abstract][Full Text] [Related]
5. Replicative senescence of normal human oral keratinocytes is associated with the loss of telomerase activity without shortening of telomeres.
Kang MK; Guo W; Park NH
Cell Growth Differ; 1998 Jan; 9(1):85-95. PubMed ID: 9438392
[TBL] [Abstract][Full Text] [Related]
6. Telomerase, checkpoints and cancer.
Harley CB; Sherwood SW
Cancer Surv; 1997; 29():263-84. PubMed ID: 9338104
[TBL] [Abstract][Full Text] [Related]
7. Telomerase, senescence and ageing.
Shawi M; Autexier C
Mech Ageing Dev; 2008; 129(1-2):3-10. PubMed ID: 18215413
[TBL] [Abstract][Full Text] [Related]
8. Multiple pathways to cellular senescence: role of telomerase repressors.
Oshimura M; Barrett JC
Eur J Cancer; 1997 Apr; 33(5):710-5. PubMed ID: 9282109
[TBL] [Abstract][Full Text] [Related]
9. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA
Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644
[TBL] [Abstract][Full Text] [Related]
10. Senescence and immortalization: role of telomeres and telomerase.
Shay JW; Wright WE
Carcinogenesis; 2005 May; 26(5):867-74. PubMed ID: 15471900
[TBL] [Abstract][Full Text] [Related]
11. Telomerase as a new target for pancreatic cancer treatment.
Sato N; Mizumoto K; Nagai E; Tanaka M
J Hepatobiliary Pancreat Surg; 2002; 9(3):322-7. PubMed ID: 12353143
[TBL] [Abstract][Full Text] [Related]
12. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
Babizhayev MA; Yegorov YE
J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
[TBL] [Abstract][Full Text] [Related]
13. Seeding drug discovery: integrating telomerase cancer biology and cellular senescence to uncover new therapeutic opportunities in targeting cancer stem cells.
Keith WN; Thomson CM; Howcroft J; Maitland NJ; Shay JW
Drug Discov Today; 2007 Aug; 12(15-16):611-21. PubMed ID: 17706542
[TBL] [Abstract][Full Text] [Related]
14. Drug insight: Cancer cell immortality-telomerase as a target for novel cancer gene therapies.
Keith WN; Bilsland A; Hardie M; Evans TR
Nat Clin Pract Oncol; 2004 Dec; 1(2):88-96. PubMed ID: 16264826
[TBL] [Abstract][Full Text] [Related]
15. [Biochemistry of space and time (telomeres, telomerases, and longevity of cell populations and multicellular organisms].
Golubev AG
Biokhimiia; 1996 Nov; 61(11):2045-59. PubMed ID: 9004864
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel effect of hPinX1 on hTERT nucleolar localization.
Lin J; Jin R; Zhang B; Yang PX; Chen H; Bai YX; Xie Y; Huang C; Huang J
Biochem Biophys Res Commun; 2007 Feb; 353(4):946-52. PubMed ID: 17198684
[TBL] [Abstract][Full Text] [Related]
17. Cellular senescence and cancer.
Wynford-Thomas D
J Pathol; 1999 Jan; 187(1):100-11. PubMed ID: 10341711
[TBL] [Abstract][Full Text] [Related]
18. Hallmarks of telomeres in ageing research.
Shay JW; Wright WE
J Pathol; 2007 Jan; 211(2):114-23. PubMed ID: 17200948
[TBL] [Abstract][Full Text] [Related]
19. Telomeres and telomerase biology in vertebrates: progress towards a non-human model for replicative senescence and ageing.
Davis T; Kipling D
Biogerontology; 2005 Dec; 6(6):371-85. PubMed ID: 16518699
[TBL] [Abstract][Full Text] [Related]
20. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
